Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2018-06-04 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Shi Fang-Hong,Li Hao,Cui Min,Zhang Zai-Li,Gu Zhi-Chun,Liu Xiao-Yan

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference45 articles.

1. Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial;Ahmann;Diabetes Care,2018

2. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial;Ahrén;Lancet Diabetes Endocrinol.,2017

3. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial;Aroda;Lancet Diabetes Endocrinol.,2017

4. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe?;Butler;Diabetes Care,2013

5. Role of adenosine-guided pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a meta-analysis;Chen;Europace,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness of 0.5 mg and 1mg of semaglutide in patients with type two diabetes and predictors of response: a retrospective cohort study;Frontiers in Endocrinology;2024-08-14

2. Cross-sectional analysis of the association between household food insecurity and mental health conditions in children aged 5–11 years in Canada;BMJ Open;2024-06

3. Adverse effects with semaglutide: a protocol for a systematic review with meta-analysis and trial sequential analysis;BMJ Open;2024-06

4. Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023;Diabetes Therapy;2024-05-22

5. The effect of incretin-based drugs on the riks of acute pancreatitis: a review;Journal of Diabetes & Metabolic Disorders;2024-05-05